Tolosa E - Search Results

1

[Efficacy and safety of posteroventral pallidotomy for the treatment of advanced Parkinson's disease].

Molinuevo JL, Valldeoriola F, Rumià J, Nobbe FA, Ferrer E, Tolosa E. Molinuevo JL, et al. Among authors: tolosa e. Med Clin (Barc). 2000 Feb 19;114(6):205-8. Med Clin (Barc). 2000. PMID: 10757100 Spanish.

2

Treatment of behavioural disturbances in Parkinson's disease.

Valldeoriola F, Nobbe FA, Tolosa E. Valldeoriola F, et al. Among authors: tolosa e. J Neural Transm Suppl. 1997;51:175-204. doi: 10.1007/978-3-7091-6846-2_15. J Neural Transm Suppl. 1997. PMID: 9470138 Review.

3

[New pharmacologic strategies for the treatment of Parkinson disease].

Tolosa E, Molinuevo JL, Valldeoriola F, Pastor P. Tolosa E, et al. Neurologia. 1999 May;14 Suppl 1:46-53. Neurologia. 1999. PMID: 10377729 Review. Spanish.

4

Cognitive and behavioral changes after unilateral posteroventral pallidotomy: relationship with lesional data from MRI.

Junqué C, Alegret M, Nobbe FA, Valldeoriola F, Pueyo R, Vendrell P, Tolosa E, Rumià J, Mercader JM. Junqué C, et al. Among authors: tolosa e. Mov Disord. 1999 Sep;14(5):780-9. doi: 10.1002/1531-8257(199909)14:5<780::aid-mds1010>3.0.co;2-g. Mov Disord. 1999. PMID: 10495039

5

Contribution of neurophysiological guidance to stereotactic posteroventral pallidotomy for Parkinson's disease.

Molinuevo JL, Valldeoriola F, Rumià J, Nobbe FA, Martínez R, Ferrer E, Tolosa E. Molinuevo JL, et al. Among authors: tolosa e. Acta Neurochir (Wien). 1999;141(11):1195-201. doi: 10.1007/s007010050418. Acta Neurochir (Wien). 1999. PMID: 10592120

6

Pallidotomy and quality of life in patients with Parkinson's disease: an early study.

Martínez-Martín P, Valldeoriola F, Molinuevo JL, Nobbe FA, Rumià J, Tolosa E. Martínez-Martín P, et al. Among authors: tolosa e. Mov Disord. 2000 Jan;15(1):65-70. doi: 10.1002/1531-8257(200001)15:1<65::aid-mds1011>3.0.co;2-y. Mov Disord. 2000. PMID: 10634243

7

Effects of unilateral posteroventral pallidotomy on 'on-off' cognitive fluctuations in Parkinson's disease.

Alegret M, Vendrell P, Junqué C, Valldeoriola F, Nobbe FA, Rumià J, Tolosa E. Alegret M, et al. Among authors: tolosa e. Neuropsychologia. 2000;38(5):628-33. doi: 10.1016/s0028-3932(99)00105-0. Neuropsychologia. 2000. PMID: 10689039 Clinical Trial.

8

Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.

Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, Ferrer E. Molinuevo JL, et al. Among authors: tolosa e. Arch Neurol. 2000 Jul;57(7):983-8. doi: 10.1001/archneur.57.7.983. Arch Neurol. 2000. PMID: 10891980 Clinical Trial.

9

[Sporadic and familial Parkinson's disease: comparative study].

Muñoz E, Pastor P, José Martí M, Valldeoriola F, Oliva R, Tolosa E. Muñoz E, et al. Among authors: tolosa e. Med Clin (Barc). 2001 May 5;116(16):601-4. doi: 10.1016/s0025-7753(01)71919-7. Med Clin (Barc). 2001. PMID: 11412643 Spanish.

10

Mid-stage parkinsonism with mild motor fluctuations.

Tolosa E, Valldeoriola F. Tolosa E, et al. Clin Neuropharmacol. 1994;17 Suppl 2:S19-31. Clin Neuropharmacol. 1994. PMID: 9358192 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters